Salveo Capital

Salveo Capital

Salveo Capital is a Chicago-based company founded in 2015 by Michael Gruber.

Salveo Capital is a private equity firm in Chicago that focuses on the legalized cannabis industry. Founded 2015 in Chicago, Illinois by Michael Gruber, it invests in debt, early stage ventures, private equity, and seed. Its portfolio companies include PathogenDx, Front Range Biosciences, Coda Signature, KelSie Biotech, Ascend Wellness, Wurk, Harborside, and Treez. As of March 2020, Salveo Capital has made 17 investments. Their most recent investment was on September 30, 2019, when PathogenDx raised $7.5M. Salveo Capital has raised a single venture fund, Salveo Fund I. This fund was announced on September 11, 2019 and raised a total of $22.3M. The firm seeks to invest in the cultivation centers, dispensaries, ancillary products, industry support services, software, and technology sectors surrounding the legal marijuana industry.

Timeline

2015

Founded

Funded Companies

Company
Description
Industry
Website
Location
Front Range Biosciences

Agriculture science for cannabis company

Biotechnology
Fort Collins, Colorado
Wurk

Wurk is a workforce management software for cannabis. Payroll, time keeping, scheduling, 280E management, onboarding, HR consulting, etc.

Software
Denver
PathogenDX

Agriculture
Harborside

Harborside is a cannabis company.

Cannabis (drug)
California
Ascend Wellness Holdings

Ascend Wellness Holdings is a Boston-based company.

Agriculture
Boston
5 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Jeff Howard

Managing Partner

Amy Articolo

Employee

Michael Gruber

Founder

Thomas Mazarakis

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Front Range Biosciences

Ascend Wellness

Coda Signature

Harborside

KelSie Biotech

PathogenDx

Treez

Wurk

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.